Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI